| Literature DB >> 23087765 |
Seyyed Mohammad Miri1, Azam Raoofi, Zahra Heidari.
Abstract
BACKGROUND: Citation analysis as one of the most widely used methods of bibliometrics can be used for computing the various impact measures for scholars based on data from citation databases. Journal Citation Reports (JCR) from Thomson Reuters provides annual report in the form of impact factor (IF) for each journal.Entities:
Keywords: Citation Analysis; Google Scholar; Hepatitis Monthly; ISI; Impact Factor; Scopus
Year: 2012 PMID: 23087765 PMCID: PMC3475027 DOI: 10.5812/hepatmon.7441
Source DB: PubMed Journal: Hepat Mon ISSN: 1735-143X Impact factor: 0.660
Method of Calculating Impact Factor of Hepatitis Monthly in 2010 Based on JCR
|
|
|
| |
| Citations in 2010 to articles published in | A | B | A+B |
| Number of articles published in | C | D | C+D |
| Calculation of Impact Factor | (A+B) / (C+D) |
Total Number of Articles, Citations and Self-Citations of Two Volumes (2008 and 2009) of Hepatitis Monthly in Google Scholar, Scopus and ISI
| 29.41 | 85/100 = 0.85 | 0.600 | |||||
| 8(1) | 13 | 12 | 9 | 3 | |||
| 8(2) | 13 | 11 | 8 | 0 | |||
| 8(3) | 13 | 13 | 10 | 2 | |||
| 8(4) | 13 | 13 | 18 | 8 | |||
| 9(1) | 13 | 13 | 10 | 2 | |||
| 9(2) | 13 | 13 | 14 | 4 | |||
| 9(3) | 13 | 12 | 13 | 5 | |||
| 9(4) | 13 | 13 | 3 | 1 | |||
| Total | 104 | 100 | 85 | 25 | |||
| 29.06 | 86/91 = 0.945 | 0.670 | |||||
| 8(1) | 13 | 12 | 10 | 3 | |||
| 8(2) | 13 | 13 | 10 | 0 | |||
| 8(3) | 13 | 10 | 8 | 2 | |||
| 8(4) | 13 | 11 | 16 | 8 | |||
| 9(1) | 13 | 11 | 10 | 2 | |||
| 9(2) | 13 | 11 | 14 | 4 | |||
| 9(3) | 13 | 13 | 16 | 5 | |||
| 9(4) | 13 | 10 | 2 | 1 | |||
| Total | 104 | 91 | 86 | 25 | |||
| 30.43 | 69/87 = 0.793 | 0.551 | |||||
| 8(1) | 13 | 11 | 10 | 3 | |||
| 8(2) | 13 | 11 | 5 | 0 | |||
| 8(3) | 13 | 10 | 3 | 1 | |||
| 8(4) | 13 | 11 | 15 | 8 | |||
| 9(1) | 13 | 12 | 8 | 2 | |||
| 9(2) | 13 | 11 | 13 | 2 | |||
| 9(3) | 13 | 11 | 16 | 5 | |||
| 9(4) | 13 | 10 | 2 | 0 | |||
| Total | 104 | 87 | 69 [ | 21 |
aThe results in this section is based on JCR
bThe actual citation number based on web of science were 71 citations (missing rate in comparison with JCR calculation: 4%)
Comparison of Citations to the Top 20 Articles of Hepatitis Monthly in ISI, GS and Sc During 2008-9
| Hepatitis B Virus Infection in Iran: A Systematic Review | Review Article | 8(4) | 9 | 9 | 9 |
| Hepatitis C Infection in the General Population of Iran: A Systematic Review | Review Article | 9(3) | 7 | 7 | 7 |
| Hepatitis C Virus Genotype Distribution in Shiraz, Southern Iran | Original Article | 9(2) | 3 | 3 | 3 |
| Epidemiology of Chronic Hepatitis C Virus Infection in High Risk Groups | Original Article | 8(1) | 2 | 1 | 1 |
| Study of Admission Rate of Hepatitis B Surface Antigen Positive Patients in 50 Dentistry Centers in Tehran (Spring 2003) | Brief Report | 8(1) | 2 | 2 | 2 |
| Potential Activity of Camel Milk-Amylase and Lactoferrin against Hepatitis C Virus Infectivity in HepG2 and Lymphocytes | Original Article | 8(2) | 2 | 2 | 2 |
| The Emerging Extrahepatic Manifestations of Hepatitis C Virus Infection in Chronic Hepatitis and Mixed Cryoglobulinemia | Review Article | 8(3) | 2 | 3 | 2 |
| We Have More Data Regarding Epidemiology of Hepatitis D in Iran but There are Defects to be Filled Yet! | Editorial | 8(4) | 2 | 2 | 2 |
| Meningoencephalitis of Hepatitis A in Adult Man: A Case Report | Case Report | 8(4) | 2 | 2 | 2 |
| Comparison of Seroepidemiology and Transmission Modes of Viral Hepatitis C in Iran and Pakistan | Review Article | 9(1) | 2 | 3 | 3 |
| Hepatitis B Markers in Isfahan, Central Iran: A Population-Based Study | Original Article | 9(1) | 2 | 5 | 2 |
| Trends in Seroprevalence of Hepatitis B, Hepatitis C, HIV, and Syphilis Infections in Iranian Blood Donors from 2003 to 2005 | Original Article | 9(1) | 2 | 2 | 3 |
| Prevalence of Hepatitis B and C Infection in Hemodialysis Patients of Rasht (Center of Guilan Province, Northern Part of Iran) | Original Article | 9(1) | 2 | 2 | 3 |
| Distribution of Hepatitis C Virus Genotypes in Iran: A Population-Based Study | Original Article | 9(2) | 2 | 1 | 2 |
| Thyroid Dysfunction in Patients with Chronic Viral Hepatitis B and C during Alpha Interferon Therapy | Original Article | 9(2) | 2 | 2 | 2 |
| Seroprevalence of Hepatitis B Virus among Pregnant Women in Northern Turkey | Brief Report | 9(2) | 2 | 1 | 2 |
| Mass Vaccination Campaign against Hepatitis B in Adolescents in Iran: Estimating Coverage using Administrative Data | Original Article | 9(3) | 2 | 2 | 2 |
| Hepatitis B Infection in Hemodialysis Patients in Tehran Province, Iran | Original Article | 9(3) | 2 | 2 | 2 |
| Seroprotection of Hepatitis B Vaccine and Need for Booster Dose: A Meta-Analysis | Review Article | 9(4) | 2 | 2 | 1 |
| Hepatitis D Is a Forgotten Problem in Hemodialysis Patients in the World | Editorial | 8(1) | 1 | 0 | 0 |
aAbbreviations: GS, Google Scholar; ISI, Institute for Scientific Information; Sc, Scopus
Figure 1Comparison of Number of Citations in ISI, GS, and Sc Based on Article Types Published in Hepatitis Monthly (2008, 2009)
Distribution of the Top 20 Journals Which Cited in 2010 to Published Articles of Hepatitis Monthly (Data Gathered From JCR, ISI, 2010)
| - | All Journals | - | 152 | 24 | 32 | 37 | 29 |
| 0.36 | Iran Red Crescent Med | Iran | 24 | 3 | 8 | 6 | 4 |
| 1.24 | Asian Pac J Cancer P | Japan | 5 | 0 | 1 | 1 | 1 |
| 1.986 | Arch Med Res | USA | 4 | 1 | 2 | 0 | 1 |
| 2.24 | World J Gastroentero | China | 3 | 0 | 0 | 2 | 0 |
| 1.093 | Hemodial Int | USA | 3 | 0 | 0 | 2 | 0 |
| 1.635 | J Public Health Pol | England | 3 | 0 | 1 | 1 | 1 |
| 3.502 | J Viral Hepatitis | England | 3 | 0 | 0 | 2 | 0 |
| 2.546 | Virol J | England | 3 | 0 | 2 | 0 | 0 |
| 3.84 | Liver Int | Denmark | 2 | 1 | 0 | 0 | 0 |
| 0.166 | Pak J Med Sci | Pakistan | 2 | 0 | 0 | 0 | 0 |
| 1.098 | Ther Apher Dial | Australia | 2 | 1 | 1 | 0 | 0 |
| 2.658 | Am J Nephrol | Switzerland | 2 | 0 | 1 | 0 | 1 |
| 2.551 | Clin Ther | USA | 2 | 0 | 0 | 0 | 1 |
| 6.186 | Cochrane DB Syst Rev | England | 2 | 0 | 2 | 0 | 0 |
| - | Cienc Saude Coletiva | Brazil | 1 | 0 | 0 | 0 | 1 |
| 1.75 | Am J Ind Med | USA | 1 | 0 | 0 | 1 | 0 |
| 3.841 | Anal Bioanal Chem | Germany | 1 | 0 | 0 | 0 | 1 |
| 1.867 | Ann Hepatol | Mexico | 1 | 0 | 0 | 1 | 0 |
| 1.199 | Arch Med Sci | Poland | 1 | 0 | 0 | 1 | 1.199 |
| 0.248 | Asian Biomed | Thailand | 1 | 0 | 0 | 1 | 0.248 |
Distribution of the Top 20 Journals Which Are Cited in Hepatitis Monthly in 2010 (Data Gathered From JCR, ISI, 2010)
| 10.885 | Hepatology | 90 | 5 | 7 | 5 | 15 |
| 9.334 | J Hepatol | 50 | 0 | 5 | 4 | 1 |
| 12.032 | Gastroenterology | 36 | 10 | 0 | 2 | 2 |
| 53.486 | New Engl J Med | 36 | 0 | 8 | 0 | 2 |
| 2.895 | J Med Virol | 33 | 1 | 2 | 4 | 0 |
| 3.502 | J Viral Hepatitis | 31 | 4 | 4 | 1 | 6 |
| 2.24 | World J Gastroentero | 31 | 0 | 3 | 4 | 6 |
| 6.882 | Am J Gastroenterol | 30 | 0 | 1 | 0 | 0 |
| 0.342 | Jcpsp-J Coll Physici | 20 | 0 | 1 | 2 | 2 |
| 3.572 | Vaccine | 19 | 0 | 1 | 0 | 3 |
| 2.41 | J Gastroen Hepatol | 19 | 0 | 3 | 2 | 1 |
| 33.633 | Lancet | 16 | 0 | 2 | 0 | 0 |
| 1.348 | Arch Iran Med | 14 | 0 | 0 | 1 | 1 |
| 2.06 | Digest Dis Sci | 13 | 0 | 0 | 3 | 2 |
| 10.614 | Gut | 12 | 0 | 0 | 0 | 0 |
| - | J Pak Med Assoc | 12 | 0 | 0 | 1 | 0 |
| 16.729 | Ann Intern Med | 11 | 0 | 0 | 0 | 0 |
| 5.189 | J Virol | 10 | 0 | 0 | 0 | 0 |
| 3.564 | Nephrol Dial Transpl | 9 | 0 | 0 | 1 | 0 |
| 1.756 | Intervirology | 9 | 1 | 1 | 3 | 0 |